Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PTPRC | P08575 | 1/20 | 0.40 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26100458 | 0.94 | LMNA (0.42) | LTB4RLMNAMAPTTBXAS1CNR2 | |
| SCHEMBL14265500 | 0.93 | TBXAS1 (0.42) | LTB4RLMNAPPARGPPARAFAAH | |
| SCHEMBL19331603 | 0.90 | PPARG (0.43) | LTB4RLMNAPPARGPPARATBXAS1 | |
| SCHEMBL16705775 | 0.90 | TBXAS1 (0.40) | LTB4RLMNAPPARGPPARAFAAH | |
| SCHEMBL1291773 | 0.89 | LMNA (0.40) | LTB4RLMNAMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL30887240 | 0.87 | TBXA2R (0.43) | LTB4RMAPTPPARATBXAS1HDAC3 | |
| SCHEMBL31528916 | 0.87 | TBXA2R (0.43) | LTB4RMAPTPPARATBXAS1HDAC3 | |
| SCHEMBL31528895 | 0.87 | TBXA2R (0.43) | LTB4RMAPTPPARATBXAS1HDAC3 | |
| SCHEMBL19405748 | 0.87 | TBXA2R (0.43) | LTB4RMAPTPPARATBXAS1HDAC3 | |
| SCHEMBL28691927 | 0.87 | TBXA2R (0.43) | LTB4RMAPTPPARATBXAS1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1971347-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | claimed |
| WO-2007075798-A9 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN INCREASED LUNG DEPOSITION | VERUS PHARMACEUTICALS INC (US) | 2007-08-23 | — | — | WO | claimed |
| WO-2007075800-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | claimed |
| EP-1973550-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN ENHANCED PHARMACOKINETIC PROFILE | Tika Läkemedel AB (SE) | 2008-10-01 | — | — | EP | disclosed |
| EP-1971346-A2 | SYSTEMS AND METHODS FOR THE DELIVERY OF CORTICOSTEROIDS | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| EP-1971347-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS | Tika Läkemedel AB (SE) | 2008-09-24 | — | — | EP | disclosed |
| US-7348173-B2 | Fatty-acid amide hydrolase | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-03-25 | — | — | US | disclosed |
| EP-0970195-B1 | FATTY-ACID AMIDE HYDROLASE | SCRIPPS RESEARCH INST (US) | 2007-10-17 | — | — | EP | disclosed |
| WO-2007075799-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS HAVING AN ENHANCED PHARMACOKINETIC PROFILE | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075800-A2 | METHODS AND SYSTEMS FOR THE DELIVERY OF CORTICOSTEROIDS | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075963-A2 | SYSTEMS AND METHODS FOR THE DELIVERY OF CORTICOSTEROIDS | TIKA LÄKEMEDEL AB (SE) | 2007-07-05 | — | — | WO | disclosed |
| US-20020187542-A1 | Fatty-acid amide hydrolase | THE SCRIPPS RESEARCH INSTITUTE (US) | 2002-12-12 | — | — | US | disclosed |
| EP-0970195-A4 | FATTY-ACID AMIDE HYDROLASE | SCRIPPS RESEARCH INST (US) | 2001-12-05 | — | — | EP | disclosed |
| US-6271015-B1 | A POLYPEPTIDE HAVING AN AMINO ACID SEQUENCE THAT HYDROLYSIZES CIS-9,10-OCTADECENOAMIDE AND OTHER SOPORIFIC FATTY ACID AMIDES; THERAPY FOR SLEEP DISORDERS AND NARCOLEPSY | THE SCRIPPS RESEARCH INSTITUTE | 2001-08-07 | — | — | US | disclosed |
| EP-0833899-A4 | CIS-9,10-OCTADECENOAMIDASE | SCRIPPS RESEARCH INST (US) | 2000-06-28 | — | — | EP | disclosed |
| EP-0970195-A1 | FATTY-ACID AMIDE HYDROLASE | The Scripps Research Institute (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998020119-A9 | FATTY-ACID AMIDE HYDROLASE | — | 1998-11-05 | — | — | WO | disclosed |
| WO-1998020119-A1 | FATTY-ACID AMIDE HYDROLASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-05-14 | — | — | WO | disclosed |
| EP-0833899-A1 | CIS-9,10-OCTADECENOAMIDASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-04-08 | — | — | EP | disclosed |
| WO-1996041869-A1 | CIS-9,10-OCTADECENOAMIDASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 1996-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020187542-A1 | Fatty-acid amide hydrolase | FAAH, FAAH2, APEH | LTB4R 1947/4885LMNA 3794/4885PPARG 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.